News
Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous ...
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or ...
Adding Zyprexa to ondansetron cut nausea and vomiting safely in abdominal/pelvic radiation with low-emetogenic capecitabine.
Adding subcutaneous sasanlimab to BCG improved recurrence-free survival in non–muscle-invasive bladder cancer, according to Dr. Petros Grivas.
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced ...
One of the unique characteristics of blood cancer is that it is not able to be seen. There are no surgery scars, loss of hair ...
The FDA granted orphan drug designation to MVdeltaC, a measles virus-based immunotherapy, for pleural mesothelioma, ...
Patients with oligometastatic lung cancer may live longer with surgery, but experts stress the need for multidisciplinary ...
Katherine has an exquisite instinct for understanding that there is a context to each patient’s diagnosis that is just as ...
Akeega Combo Delays Progression in HRR+ Castration-Sensitive Prostate Cancer ...
Natalie Schnaitmann discusses urgent supportive care gaps younger women with cancer encounter, and how they affect long-term quality of life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results